Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia
NCT ID: NCT01504893
Last Updated: 2022-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
984 participants
INTERVENTIONAL
2013-09-30
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary endpoint: Evaluation of postoperative ARDS incidence
Secondary endpoint: Evaluation od PPC incidence and postoperative outcomes (other complications, unplanned Intensive Care Admission, hospital and ICU length of stay, in-hospital mortality)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mechanical Ventilation During Cardiac Surgery
NCT02090205
Individualized Perioperative Open-Lung Ventilatory Strategy During One-Lung Ventilation
NCT03182062
Individualized Perioperative Open Lung Ventilatory Strategy
NCT02158923
Evaluation of Ventilatory Strategies During Laparoscopic Surgery
NCT01923038
Preconditioning of One-lung Ventilation
NCT03282032
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
International literature reports a wide use of tidal volume around 5-6 ml/kg predicted body weight (PBW) during one lung ventilation (OLV) but variable use of PEEP and alveolar recruitment maneuver (ARM).
The aim of this multicenter, randomized, single blind study is to determine if a protective ventilatory strategy during OLV based on low tidal volume, PEEP and alveolar recruitment maneuver compared to conventional strategy can reduce ARDS and PPCs after major pulmonary resection.
Primary outcome is the incidence of in-hospital ARDS.
Secondary outcomes are in-hospital incidence of postoperative pulmonary complications (PPCs), major cardiovascular events, unplanned Intensive Care Unit admission, in-hospital length of stay and mortality
RANDOMIZATION
Patients are randomly assigned to receive protective or conventional OLV according to a computer-generated randomization list (1:1 ratio) before anesthesia induction.
Patients are blinded to the treatment. Anesthesiologists and surgeons are unblinded to the treatment during the surgical procedure and the postoperative outcome assessment.
MEASUREMENTS
Intraoperative collection of ventilatory settings, airway pressures, arterial blood gases analysis at the following time points:
T1: two lung ventilation in supine position before placing the patient in lateral decubitus; T2: 30 minutes after OLV start; T3: 60 minutes after OLV start; T4: 20 minutes after lobectomy/pneumonectomy (during OLV); T5: 15 minutes after ARM in supine position and during two lung ventilation.
Postoperative data collection 1, 12, 24, 36, 48 hours after surgery and at discharge. Arterial blood gas analysis will be performed 1 hour after extubation and 24 and 72 hours after surgery (or in case of respiratory insufficiency).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Protective
Two-lung ventilation (TLV): tidal volume = 8 mL / kg PBW, peak airway pressure ≤ 25 cm H2O, I: E = 1:2; after lung re-expansion to the closure of the chest will set a PEEP of 5 cmH2O
OLV (OLV): 4 mL / kg PBW, peak airway pressure ≤ 35 cmH2O, respiratory rate \<30, I:E = 1:2 / 1:3.
During OLV in case of desaturation (before increasing the FiO2) and every 60 minutes alveolar recruitment maneuvers followed by the setting of PEEP to 5 cmH2O
Protective one lung ventilation
Low tidal volume, PEEP and alveolar recruitment maneuver
Conventional
Two-lung ventilation (TLV): tidal volume = 8 mL / kg PBW, peak airway pressure ≤ 25 cmH2O; I: E = 1:2; after lung re-expansion to the closure of the chest PEEP set to 5 cmH2O
OLV (OLV): 6 mL / kg PBW, peak airway pressure ≤ 35 cmH2O; I: E = 1:2.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Protective one lung ventilation
Low tidal volume, PEEP and alveolar recruitment maneuver
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA IV
* Elective thoracotomies or thoracoscopic major lung resection surgery (lobectomy, bilobectomy, pneumonectomy)
Exclusion Criteria
* Wedge resection or atypical resection
* Non-resective lung surgery requiring OLV
* Patients \< 18 years
* BMI \< 20 and BMI \> 29
* Heart disease with ejection fraction \<50% and/or severe valvulopathy
* Pulmonary hypertension
* Renal failure requiring dialytic treatment
* Drug addiction
* Mental retardation, depression and psychiatric disease
* Motor or sensory deficit
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Ospedaliera S. Maria della Misericordia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Giorgio Della Rocca
M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giorgio Della Rocca, MD, Prof
Role: PRINCIPAL_INVESTIGATOR
Azienda Ospedaliero-Universitaria S. Maria della Misericordia - Udine. Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ASST Papa Giovanni XXIII
Bergamo, , Italy
IRCCS Policlinico Sant'Orsola-Malpighi
Bologna, , Italy
Ospedale Centrale
Bolzano, , Italy
Azienda Ospedaliera Brotzu - Ospedale Oncologico Businco
Cagliari, , Italy
IRCCS Ospedale Policlinico San Martino
Genova, , Italy
Fondazione IRCCS Istituto Nazionale Tumori
Milan, , Italy
IRCCS Ospedale San Raffaele
Milan, , Italy
Azienda Ospedaliera-Universitaria
Modena, , Italy
Istituto Nazionale Tumori Fondazione Pascale
Napoli, , Italy
Azienda Ospedaliero-Universitaria
Padua, , Italy
IRCCS Centro di Riferimento Oncologico della Basilicata
Rionero in Vulture, , Italy
Istituto Nazionale Tumori Regina Elena
Rome, , Italy
Azienda Ospedaliera Universitaria Senese
Siena, , Italy
Ospedale di Cattinara
Trieste, , Italy
Department of Anesthesia and Intensive Care Unit
Udine, , Italy
Ospedale di Circolo e Fondazione Macchi
Varese, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Yang M, Ahn HJ, Kim K, Kim JA, Yi CA, Kim MJ, Kim HJ. Does a protective ventilation strategy reduce the risk of pulmonary complications after lung cancer surgery?: a randomized controlled trial. Chest. 2011 Mar;139(3):530-537. doi: 10.1378/chest.09-2293. Epub 2010 Sep 9.
Licker M, Diaper J, Villiger Y, Spiliopoulos A, Licker V, Robert J, Tschopp JM. Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery. Crit Care. 2009;13(2):R41. doi: 10.1186/cc7762. Epub 2009 Mar 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ALI01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.